Maxim Gureev

547 total citations
48 papers, 368 citations indexed

About

Maxim Gureev is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Maxim Gureev has authored 48 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Maxim Gureev's work include Synthesis and biological activity (7 papers), Synthesis and Catalytic Reactions (5 papers) and Synthesis and Biological Evaluation (5 papers). Maxim Gureev is often cited by papers focused on Synthesis and biological activity (7 papers), Synthesis and Catalytic Reactions (5 papers) and Synthesis and Biological Evaluation (5 papers). Maxim Gureev collaborates with scholars based in Russia, Italy and Finland. Maxim Gureev's co-authors include Mikhail Krasavin, А. В. Гарабаджиу, Alexander S. Novikov, Vyacheslav G. Tribulovich, Alexander S. Mikherdov, Vadim P. Boyarskiy, Dmitry Dar’in, Sergey V. Baykov, Sophia S. Borisevich and Нариман Ф. Салахутдинов and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Maxim Gureev

46 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxim Gureev Russia	11	138	137	57	37	36	48	368
Hatem A Hejaz Palestinian Territory	13	380 2.8×	188 1.4×	66 1.2×	51 1.4×	24 0.7×	27	657
Carolina D. Duarte Brazil	9	177 1.3×	293 2.1×	46 0.8×	49 1.3×	49 1.4×	11	528
Huiqiang Zhou United States	14	309 2.2×	200 1.5×	52 0.9×	30 0.8×	42 1.2×	21	540
Jens Schamberger Germany	8	175 1.3×	57 0.4×	27 0.5×	20 0.5×	62 1.7×	11	315
George Pairas Greece	11	227 1.6×	294 2.1×	43 0.8×	15 0.4×	28 0.8×	42	516
Chiranjeev Sharma India	14	194 1.4×	131 1.0×	53 0.9×	26 0.7×	15 0.4×	23	386
Miklós Idei Hungary	16	300 2.2×	127 0.9×	72 1.3×	35 0.9×	43 1.2×	39	638
Jo Alen Belgium	11	144 1.0×	118 0.9×	21 0.4×	39 1.1×	23 0.6×	17	395
R. N. V. Krishna Deepak Singapore	12	302 2.2×	35 0.3×	34 0.6×	27 0.7×	44 1.2×	17	450
Ashok C. Bajji United States	11	391 2.8×	152 1.1×	50 0.9×	26 0.7×	23 0.6×	24	527

Countries citing papers authored by Maxim Gureev

Since Specialization

Citations

This map shows the geographic impact of Maxim Gureev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Gureev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Gureev more than expected).

Fields of papers citing papers by Maxim Gureev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Gureev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Gureev. The network helps show where Maxim Gureev may publish in the future.

Co-authorship network of co-authors of Maxim Gureev

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Gureev. A scholar is included among the top collaborators of Maxim Gureev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Gureev. Maxim Gureev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gureev, Maxim, et al.. (2025). 3-(3-Azabicyclo[2, 2, 1]heptan-2-yl)-1,2,4-oxadiazoles as Novel Potent DPP-4 Inhibitors to Treat T2DM. Pharmaceuticals. 18(5). 642–642.

Gureev, Maxim, et al.. (2024). The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Mycobacterium tuberculosis. Molecules. 29(13). 3071–3071. 2 indexed citations

Gureev, Maxim, Natalia A. Danilkina, Alexander F. Khlebnikov, & Ирина А. Балова. (2024). Docking and Molecular Dynamics Studies on DNA-Heterocyclic Enediynes Interaction to Identify the Preferred Binding Mode. Russian Journal of General Chemistry. 94(S1). S100–S119. 1 indexed citations

Kalinin, Stanislav, Dmitry Dar’in, Maxim Gureev, et al.. (2023). A new way of synthesizing heterocyclic primary sulfonamide probes for carbonic anhydrase. Mendeleev Communications. 33(3). 325–327. 1 indexed citations

Chen, Deng, Maxim Gureev, Zhangping Xiao, et al.. (2023). Allosteric Inhibitors of Macrophage Migration Inhibitory Factor (MIF) Interfere with Apoptosis-Inducing Factor (AIF) Co-Localization to Prevent Parthanatos. Journal of Medicinal Chemistry. 66(13). 8767–8781. 6 indexed citations

Babich, Olga, et al.. (2023). In Vitro Study of Biological Activity of Tanacetum vulgare Extracts. Pharmaceutics. 15(2). 616–616. 17 indexed citations

Golovin, Andrey V., Maxim Gureev, Mikhail V. Biryukov, et al.. (2023). Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators—Inhibitors of Bacterial Cystathionine γ-Lyase. International Journal of Molecular Sciences. 24(22). 16331–16331. 6 indexed citations

Gureev, Maxim, et al.. (2023). Novel 1,2,4-Triazole- and Tetrazole-Containing 4H-Thiopyrano[2,3-b]quinolines: Synthesis Based on the Thio-Michael/aza-Morita–Baylis–Hillman Tandem Reaction and Investigation of Antiviral Activity. Molecules. 28(21). 7427–7427. 3 indexed citations

Krasavin, Mikhail, Anatoly A. Peshkov, Evgeniya V. Efimova, et al.. (2022). Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-N-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders. International Journal of Molecular Sciences. 23(19). 11579–11579. 7 indexed citations

10.

Sapegin, Alexander, Л. А. Краева, Maxim Gureev, et al.. (2022). Novel 5-Nitrofuran-Tagged Imidazo-Fused Azines and Azoles Amenable by the Groebke–Blackburn–Bienaymé Multicomponent Reaction: Activity Profile against ESKAPE Pathogens and Mycobacteria. Biomedicines. 10(9). 2203–2203. 3 indexed citations

11.

Gureev, Maxim, et al.. (2022). Design, Synthesis and Biological Evaluation of Neogliptin, a Novel 2-Azabicyclo[2.2.1]heptane-Based Inhibitor of Dipeptidyl Peptidase-4 (DPP-4). Pharmaceuticals. 15(3). 273–273. 7 indexed citations

12.

Danilkina, Natalia A., et al.. (2022). Functionalized 10-Membered Aza- and Oxaenediynes through the Nicholas Reaction. Molecules. 27(18). 6071–6071. 5 indexed citations

13.

Nocentini, Alessio, Maxim Gureev, Arto Urtti, et al.. (2022). 5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1005–1011. 7 indexed citations

14.

Krasavin, Mikhail, Ilya Sukhanov, Evgeniya V. Efimova, et al.. (2022). Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders. Biomolecules. 12(11). 1650–1650. 6 indexed citations

15.

Dar’in, Dmitry, et al.. (2021). 1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1968–1983. 2 indexed citations

16.

Gubskiy, Ilya, Alexey A. Lagunin, Leonid Gubsky, et al.. (2021). A Novel Phenylpyrrolidine Derivative: Synthesis and Effect on Cognitive Functions in Rats with Experimental Ishemic Stroke. Molecules. 26(20). 6124–6124. 8 indexed citations

17.

Dar’in, Dmitry, et al.. (2021). Three-component Castagnoli-Cushman reaction with ammonium acetate delivers 2-unsubstituted isoquinol-1-ones as potent inhibitors of poly(ADP-ribose) polymerase (PARP). Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1916–1921. 5 indexed citations

18.

Borisevich, Sophia S., Maxim Gureev, Оlga I. Yarovaya, et al.. (2021). Can molecular dynamics explain decreased pathogenicity in mutant camphecene-resistant influenza virus?. Journal of Biomolecular Structure and Dynamics. 40(12). 5481–5492. 13 indexed citations

19.

Bakhtyukov, A. A., К. В. Деркач, Maxim Gureev, et al.. (2020). Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats. International Journal of Molecular Sciences. 21(20). 7493–7493. 20 indexed citations

20.

Dar’in, Dmitry, et al.. (2018). Non-chelating p-phenylidene-linked bis-imidazoline analogs of known influenza virus endonuclease inhibitors: Synthesis and anti-influenza activity. European Journal of Medicinal Chemistry. 161. 526–532. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact